.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Medtronic
Teva
Healthtrust
Express Scripts
Chinese Patent Office
Farmers Insurance
QuintilesIMS
Johnson and Johnson
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

EPOPROSTENOL SODIUM Drug Profile

« Back to Dashboard

Which patents cover Epoprostenol Sodium, and when can generic versions of Epoprostenol Sodium launch?

Epoprostenol Sodium is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in EPOPROSTENOL SODIUM is epoprostenol sodium. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.

Summary for Tradename: EPOPROSTENOL SODIUM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list19
Clinical Trials: see list2,362
Patent Applications: see list5,225
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPOPROSTENOL SODIUM at DailyMed

Pharmacology for Tradename: EPOPROSTENOL SODIUM

Ingredient-typeProstaglandins I
Drug ClassProstacycline Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
EPOPROSTENOL SODIUM
epoprostenol sodium
INJECTABLE;INJECTION078396-001Apr 23, 2008APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
EPOPROSTENOL SODIUM
epoprostenol sodium
INJECTABLE;INJECTION078396-002Apr 23, 2008APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKinsey
Harvard Business School
Queensland Health
Daiichi Sankyo
Covington
AstraZeneca
Fuji
Cerilliant
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot